BD receives FDA 510(k) clearance for new blood collection device

0

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and European CE marking for a new safety blood collection set” BD (2016).

BD report “BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and European CE marking for a new safety blood collection set – the BD Vacutainer® UltraTouch™ Push Button Blood Collection Set – that uses proprietary needle technology to help enhance the patient experience during this important procedure.”

Full Report

Thank you to our partners for supporting IVTEAM

Share.

Comments are closed.